Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BTB domain containing 6 (BTBD6) is a human protein encoded by the BTBD6 gene, which localizes predominantly in the cytoplasm and cytosol. It serves as an adapter protein for the Cul3 E3 ubiquitin-protein ligase complex, and is implicated in late neuronal development, muscle formation, and proper embryogenesis[5][3][1]. The protein contains a BTB/POZ domain—a highly conserved motif involved in protein-protein interactions that mediates oligomerization and interactions with non-BTB proteins[6][8]. BTBD6 is part of a broader family of BTB-domain containing proteins, which play diverse roles in transcriptional regulation, chromatin remodeling, cytoskeletal mobility, and the ubiquitination pathway[8][4]. Although BTBD6 is associated with genetic diseases such as cone-rod dystrophy 1[1], there are currently no known drugs targeting BTBD6, and it is not considered a therapeutic target (e.g., receptor, enzyme, transporter) at this time. There are no established biomarkers or safety concerns associated with BTBD6 in clinical practice[1][5][3][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BTB domain containing 6 (BTBD6).